Aprepitant for the Prevention of Chemotherapy Induced Nausea and Vomiting (CINV)(0869-130)(COMPLETED)

Clinical trial NCT00337727 · COMPLETED

Trial details

NCT number: NCT00337727
Sponsor: Merck Sharp & Dohme LLC
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Chemotherapy-Induced Nausea and Vomiting

Start date: 2007-01-01
Primary completion: 2008-10-28
Enrollment: 848

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.